S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
All the trading advice you’ve ever received boils down to this (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
All the trading advice you’ve ever received boils down to this (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
All the trading advice you’ve ever received boils down to this (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
All the trading advice you’ve ever received boils down to this (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
All the trading advice you’ve ever received boils down to this (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
All the trading advice you’ve ever received boils down to this (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
All the trading advice you’ve ever received boils down to this (Ad)
Marvell Technology at a critical pivot: 30% upside is possible
What is dividend harvesting?
All the trading advice you’ve ever received boils down to this (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

CBIZ Stock Price, News & Analysis (NYSE:CBZ)

$58.70
-0.55 (-0.93%)
(As of 12/5/2023 ET)
Compare
Today's Range
$58.27
$59.07
50-Day Range
$50.13
$59.25
52-Week Range
$45.22
$59.27
Volume
191,343 shs
Average Volume
206,940 shs
Market Capitalization
$2.93 billion
P/E Ratio
24.36
Dividend Yield
N/A
Price Target
$63.00

CBIZ MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
7.3% Upside
$63.00 Price Target
Short Interest
Healthy
1.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.78mentions of CBIZ in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$682,921 Sold Last Quarter
Proj. Earnings Growth
12.08%
From $2.40 to $2.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Business Services Sector

93rd out of 285 stocks

Business Services, Not Elsewhere Classified Industry

39th out of 82 stocks


CBZ stock logo

About CBIZ Stock (NYSE:CBZ)

CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services. The Benefits and Insurance Services provides employee benefits consulting, payroll/human capital management, property and casualty insurance, and retirement and investment services. The National Practices segment offers information technology managed networking and hardware, and health care consulting services. The company primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. CBIZ, Inc. was incorporated in 1987 and is headquartered in Cleveland, Ohio.

CBZ Stock Price History

CBZ Stock News Headlines

CBIZ, Inc. (NYSE:CBZ) Short Interest Update
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
CBIZ (NYSE:CBZ) vs. ACV Auctions (NASDAQ:ACVA) Critical Review
20 Tax-Friendly States for High Income in the US
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Sidoti & Co. Upgrades Cbiz (CBZ)
CBIZ, Inc. (NYSE:CBZ) Q3 2023 Earnings Call Transcript
CBIZ Inc (CBZ) Reports Q3 and Nine-Month 2023 Results
CBIZ (CBZ) Q3 Earnings and Revenues Top Estimates
CBIZ REPORTS THIRD-QUARTER AND NINE-MONTH 2023 RESULTS
Accenture (ACN) Q4 Earnings Top Estimates
Cash Flow Concerns Rise as SMBs Brace for Economic Downturn
CBIZ Inc (XC4.DU)
Sidoti & Co. Downgrades Cbiz (CBZ)
See More Headlines
Receive CBZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIZ and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Research & Consulting Services
CUSIP
12480510
Employees
6,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$63.00
High Stock Price Target
$63.00
Low Stock Price Target
$63.00
Potential Upside/Downside
+7.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$105.35 million
Pretax Margin
10.84%

Debt

Sales & Book Value

Annual Sales
$1.41 billion
Cash Flow
$2.85 per share
Book Value
$14.03 per share

Miscellaneous

Free Float
47,151,000
Market Cap
$2.93 billion
Optionable
Optionable
Beta
0.77
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














CBZ Stock Analysis - Frequently Asked Questions

Should I buy or sell CBIZ stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CBIZ in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CBZ shares.
View CBZ analyst ratings
or view top-rated stocks.

What is CBIZ's stock price target for 2024?

1 analysts have issued 12-month price objectives for CBIZ's shares. Their CBZ share price targets range from $63.00 to $63.00. On average, they anticipate the company's share price to reach $63.00 in the next year. This suggests a possible upside of 7.3% from the stock's current price.
View analysts price targets for CBZ
or view top-rated stocks among Wall Street analysts.

How have CBZ shares performed in 2023?

CBIZ's stock was trading at $46.85 at the start of the year. Since then, CBZ stock has increased by 25.3% and is now trading at $58.70.
View the best growth stocks for 2023 here
.

Are investors shorting CBIZ?

CBIZ saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 472,400 shares, a decrease of 5.2% from the October 31st total of 498,500 shares. Based on an average trading volume of 207,400 shares, the short-interest ratio is presently 2.3 days. Currently, 1.0% of the company's stock are short sold.
View CBIZ's Short Interest
.

When is CBIZ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our CBZ earnings forecast
.

How were CBIZ's earnings last quarter?

CBIZ, Inc. (NYSE:CBZ) announced its quarterly earnings data on Thursday, October, 26th. The business services provider reported $0.66 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.08. The business services provider earned $410.54 million during the quarter, compared to the consensus estimate of $395.53 million. CBIZ had a net margin of 7.84% and a trailing twelve-month return on equity of 16.22%. CBIZ's revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.51 EPS.

What guidance has CBIZ issued on next quarter's earnings?

CBIZ issued an update on its FY23 earnings guidance on Thursday, October, 26th. The company provided EPS guidance of $2.36 to $2.41 for the period, compared to the consensus earnings per share estimate of $2.33. The company issued revenue guidance of +10-12% yr/yr to ~$1.55-1.58 billion, compared to the consensus revenue estimate of $1.56 billion.

What is Jerry Grisko's approval rating as CBIZ's CEO?

57 employees have rated CBIZ Chief Executive Officer Jerry Grisko on Glassdoor.com. Jerry Grisko has an approval rating of 84% among the company's employees.

What other stocks do shareholders of CBIZ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CBIZ investors own include Walt Disney (DIS), Veracyte (VCYT), Carnival Co. & (CCL), CRISPR Therapeutics (CRSP), Etsy (ETSY), Gilead Sciences (GILD), Johnson & Johnson (JNJ), KeyCorp (KEY), Altria Group (MO) and NeoGenomics (NEO).

Who are CBIZ's major shareholders?

CBIZ's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Morgan Stanley (7.78%), Burgundy Asset Management Ltd. (4.09%), Allspring Global Investments Holdings LLC (2.73%), Mawer Investment Management Ltd. (2.08%), Northern Trust Corp (1.88%) and Victory Capital Management Inc. (1.64%). Insiders that own company stock include Benaree Pratt Wiley, Chris Spurio, Jerome P Grisko, Joseph S Dimartino, Michael P Kouzelos, Rajesh Vashist, Sherrill W Hudson, Steven L Gerard, Todd J Slotkin and Ware H Grove.
View institutional ownership trends
.

How do I buy shares of CBIZ?

Shares of CBZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:CBZ) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -